Intra-venous fluids preventing severe ovarian hyperstimulation syndrome

Aboulghar, M.; Evers, Julie; Al-Inany, HG

doi:10.1002/14651858.cd001302

Search citation statements

Order By: Relevance

Paper Sections

Select...

Prevention1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

2021

Publication Types

Select...

Article6

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 19 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study postulated that high absolute or rapidly rising serum oestradiol concentrations were associated with OHSS, while lower serum oestradiol concentrations may reduce the likelihood of OHSS (64, 65). Therefore, strategies such as the GnRH antagonist which reduces oestradiol levels could prevent early OHSS in high-risk patients.…”

Section: Preventionmentioning

confidence: 99%

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome

Alamá

Bellver

Vidal

et al. 2013

Int J Endocrinol Metab

View full text Add to dashboard Cite

The GnRH analogue (agonist and antagonist GnRH) changed ovarian stimulation. On the one hand, it improved chances of pregnancy to obtain more oocytes and better embryos. This leads to an ovarian hyper-response, which can be complicated by the ovarian hyperstimulation syndrome (OHSS). On the other hand, the GnRH analogue can prevent the incidence of OHSS: GnRH antagonist protocols, GnRH agonist for triggering final oocyte maturation, either together or separately, coasting, and the GnRH analogue may prove useful for avoiding OHSS in high-risk patients. We review these topics in this article.

show abstract

Section: Preventionmentioning

confidence: 99%